These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
361 related items for PubMed ID: 12135014
1. Treatment of idiopathic gastroparesis with injection of botulinum toxin into the pyloric sphincter muscle. Miller LS, Szych GA, Kantor SB, Bromer MQ, Knight LC, Maurer AH, Fisher RS, Parkman HP. Am J Gastroenterol; 2002 Jul; 97(7):1653-60. PubMed ID: 12135014 [Abstract] [Full Text] [Related]
2. Influence of intrapyloric botulinum toxin injection on gastric emptying and meal-related symptoms in gastroparesis patients. Arts J, van Gool S, Caenepeel P, Verbeke K, Janssens J, Tack J. Aliment Pharmacol Ther; 2006 Aug 15; 24(4):661-7. PubMed ID: 16907899 [Abstract] [Full Text] [Related]
3. Botulinum toxin for the treatment of gastroparesis: a preliminary report. Lacy BE, Zayat EN, Crowell MD, Schuster MM. Am J Gastroenterol; 2002 Jun 15; 97(6):1548-52. PubMed ID: 12094882 [Abstract] [Full Text] [Related]
4. Botulinum toxin A for the treatment of delayed gastric emptying. Friedenberg FK, Palit A, Parkman HP, Hanlon A, Nelson DB. Am J Gastroenterol; 2008 Feb 15; 103(2):416-23. PubMed ID: 18070232 [Abstract] [Full Text] [Related]
9. A systematic review on intrapyloric botulinum toxin injection for gastroparesis. Bai Y, Xu MJ, Yang X, Xu C, Gao J, Zou DW, Li ZS. Digestion; 2010 Sep 15; 81(1):27-34. PubMed ID: 20029206 [Abstract] [Full Text] [Related]
13. Pyloric sphincter characteristics using EndoFLIP® in gastroparesis. Saadi M, Yu D, Malik Z, Parkman HP, Schey R. Rev Gastroenterol Mex (Engl Ed); 2018 Sep 15; 83(4):375-384. PubMed ID: 29709494 [Abstract] [Full Text] [Related]
14. Factors associated with symptom response to pyloric injection of botulinum toxin in a large series of gastroparesis patients. Coleski R, Anderson MA, Hasler WL. Dig Dis Sci; 2009 Dec 15; 54(12):2634-42. PubMed ID: 19184429 [Abstract] [Full Text] [Related]
16. Prevention of delayed gastric emptying after esophagectomy: a single center's experience with botulinum toxin. Martin JT, Federico JA, McKelvey AA, Kent MS, Fabian T. Ann Thorac Surg; 2009 Jun 15; 87(6):1708-13; discussion 1713-4. PubMed ID: 19463583 [Abstract] [Full Text] [Related]
18. [Gastroparesis--diagnosis and treatment]. Ciortescu I, Stanciu C. Rev Med Chir Soc Med Nat Iasi; 2009 Jun 15; 113(2):330-8. PubMed ID: 21495337 [Abstract] [Full Text] [Related]
19. Glucose control is not improved by accelerating gastric emptying in patients with type 1 diabetes mellitus and gastroparesis. a pilot study with cisapride as a model drug. Lehmann R, Honegger RA, Feinle C, Fried M, Spinas GA, Schwizer W. Exp Clin Endocrinol Diabetes; 2003 Aug 15; 111(5):255-61. PubMed ID: 12951630 [Abstract] [Full Text] [Related]
20. Endoscopic pyloric injection of botulinum toxin-A for the treatment of postvagotomy gastroparesis. Reddymasu SC, Singh S, Sankula R, Lavenbarg TA, Olyaee M, McCallum RW. Am J Med Sci; 2009 Mar 15; 337(3):161-4. PubMed ID: 19174691 [Abstract] [Full Text] [Related] Page: [Next] [New Search]